Date:28-Apr-2024  Time: 2:10 AM

Company Profile Get Quotes Background Board of Directors Balance Sheet Profit & Loss  Quarterly Results Financial Ratios Share Price Charts          Glenmark Pharmaceuticals Ltd Quarters:       3 4 5 6 (Rs. In Crores) Particulars Dec 2023 Sep 2023 Jun 2023 Mar 2023 Type 3Qtr 2Qtr 1Qtr 4Qtr Net Sales 1304.16 2170.40 2098.06 1874.97 Other Income 258.82 73.58 49.36 232.97 Total Income 1623.91 2306.99 2193.75 2172.01 Total Expenditure 1574.65 1809.60 1691.02 2379.75 Operating Profit 49.26 497.40 502.73 -207.74 Interest 73.60 58.19 61.93 58.86 Gross Profit -24.34 439.21 440.79 -266.60 Depreciation 51.16 49.85 48.75 46.73 Tax -53.17 9.22 38.57 84.65 Deferred Tax -1.93 77.80 81.82 -260.51 Reported Profit After Tax -20.41 302.35 271.66 -137.47 Source:Capital Market

Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774 MCX: Membership Code: 31560  Mutual Funds: ARN0843. FMC Unique Membership Code: MCX/TCM/CORP/1106 2006-07 © Senator Securities Pvt. Ltd. All rights reserved FMC Unique Membership Code: NCDEX/TCM/CORP/0760 Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified) Content powered by capitalmarket.com